跳至主要内容
临床试验/ACTRN12605000542695
ACTRN12605000542695已完成4 期

A randomised phase IV study to examine the effects of ramipril on walking distance in patients with peripheral arterial disease

Baker Heart Resaerch Institute / Alfred Hospital0 个研究点目标入组 40 人开始时间: 2005年9月28日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
ot stated 至 ot stated(—)
性别
All

入选标准

  • Ankle-brachial index of <0.9 at rest in at least one legHistory of intermittent claudication (unilateral or bilateral) which was stable for 6 monthsEvidence of superficial femoral artery stenosis or occlusion on duplex scanBlood pressure <=160/90 mmHgStable medication regimen for at least 6 months and not previously treated with ACE inhibitors.

排除标准

  • Limiting coronary artery diseaseRenal failureHistory of hypertensionHistory of type 2 diabetes mellitus.

研究者

发起方
Baker Heart Resaerch Institute / Alfred Hospital

相似试验